ESR1 and breast cancer: Luminal BC (LBC), which accounts for roughly 70% of BC cases [2], is further classified into two subtypes: LBC A: ER+/PR+, low proliferation, and generally HER2−; and LBC B: ER+/PR+, higher proliferation, with some HER2+ cases.